Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price...
Hapbee, Biotech Stock Review

Hapbee Technologies (HAPB): Updates and News Archive.

Recent Headlines UPDATED CONTINUOUSLY. June 4, 2021: Hapbee (HAPBF) Selects Accomplished...
Hapbee, Biotech Stock Review

Hapbee (HAPB) Soars 136% the First Day of Trading!

LIVE QUOTE Subscribe here for upcoming report.
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
CB Scientific, Biotech Stock Review

Adding Telehealth Play CB Scientific (CBSC) $1.10 to CoronaVirus Watch List.

MyCardia's My-Cam Offers At-Home Heart Rate Monitoring. LIVE QUOTE
CB Scientific

Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.

CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business.

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!